High-dose chemotherapy followed by autologous stem cell transplantation in pediatric patients with relapsed osteosarcoma.

Sung Han KangWanlim KimJong Seok LeeJin Kyung SuhHyery KimDong Kwan KimSe Hoon ChoiHee Won ChoHee Young JuKeon Hee YooKi Woong SungHong Hoe KooSung Wook SeoHo Joon ImJi Won LeeKyung-Nam Koh

Published in: Pediatric blood & cancer (2023)

To our knowledge, we report the first comparative cohort study that proved HDCT/ASCT does not significantly improve survival outcomes in relapsed osteosarcoma. Achievement of CR remains the most crucial factor for good survival outcomes.

Keyphrases

high dose
stem cell transplantation
acute lymphoblastic leukemia
acute myeloid leukemia
hodgkin lymphoma
multiple myeloma
diffuse large b cell lymphoma
low dose
healthcare
bone marrow
locally advanced
cell therapy
stem cells
platelet rich plasma
squamous cell carcinoma
radiation therapy
chemotherapy induced